Combination antifibrotic therapy in Idiopathic Pulmonary Fibrosis patients: real life experience in an ILD Unit.
E. Martinez Besteiro (Madrid, Spain), M. Beceiro (Madrid, Spain), M. Churruca Arróspide (Madrid, Spain), D. Mouhtar (Madrid, Spain), A. Peláez (Madrid, Spain), T. Alonso (Madrid, Spain), J. Ancochea (Madrid, Spain), C. Valenzuela (Madrid, Spain)
Source: International Congress 2022 – Promising new approaches in idiopathic interstitial pneumonias
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Martinez Besteiro (Madrid, Spain), M. Beceiro (Madrid, Spain), M. Churruca Arróspide (Madrid, Spain), D. Mouhtar (Madrid, Spain), A. Peláez (Madrid, Spain), T. Alonso (Madrid, Spain), J. Ancochea (Madrid, Spain), C. Valenzuela (Madrid, Spain). Combination antifibrotic therapy in Idiopathic Pulmonary Fibrosis patients: real life experience in an ILD Unit.. 1938
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|